RE: Buying and selling pattern10 Aug 2024 08:22
confirmed revenues (taken from the september 23 and recent prelims rns)
23 h1 - £1.2m (0.8m products, £0.4m services)
23 h2 - £1m
24 h1 - £1.0m - £1.3m
24 h2 - forecast to be at least £5.1m, partly justified because of the pharma services pipeline.
we dont know how many products have been sold, we only know product and services revenue combined was £1m - £1.3m till the end of june, which is circa the same as h1 23.
in the september rns they said services related sales of up to £2.5 million have already been made for revenues in future periods, which implies a higher proportion of future revenue would be for services.
they never forecast where the £6.45m was coming from, but whatever *** packet they wrote the calculation on, i very much doubt they were on track for by h1.
i can’t see how even £4m can be achieved this year, because there’s nothing to suggest product sales are rocking and presumably any significant services contracts wouldn’t be paid immediately.
there can’t be much debate about the missed revenue, the only sensible discussions would be around the severity of the miss and the impact of that event.